Mar 27, 2023
Which of the guidelines for use of CDK 4/6 inhibitors do you use
to guide treatment for patients with HR-positive/HER2-negative
early breast cancer?
Credit available for this activity expires: 3/27/2024
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990129?ecd=bdc_podcast_libsyn_mscpedu